Ian M. Catlett

1.9k citations
33 papers · 1.1k indexed · 1 hit paper · h-index 15
Topics
Cytokine Signaling Pathways and Interactions (19 papers)Systemic Lupus Erythematosus Research (8 papers)Psoriasis: Treatment and Pathogenesis (7 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaNature Immunology

In The Last Decade

Ian M. Catlett

32 papers receiving 1.1k citations

Hit Papers

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in System...202220262023202420224080120

Peers

Ian M. Catlett
Comparison fields: 5 of 79
  • Immunology 632
  • Oncology 304
  • Epidemiology 304
  • Rheumatology 214
  • Molecular Biology 186
Replace Melanie Poulin-Costello with:
Melanie Poulin-Costello Canada
Sarbani Ghosh United States
Edward Greeno United States
Marguerite Stas Belgium
Kuan‐Yu Chen Taiwan
Samuel Litwin United States
Naohito Fujishima Japan
Laetitia Finzi France
Morena Fasano Italy
Yutaka Sasaki Japan
Ian M. Catlett relative to Melanie Poulin-Costello Canada Melanie Poulin-Costello's profile →
Citations per field
00.5×10×16×
Melanie Poulin-Costello · 1×
Citations per year

Countries citing papers authored by Ian M. Catlett

Since Specialization
Citations

This map shows the geographic impact of Ian M. Catlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Catlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Catlett more than expected).

Fields of papers citing papers by Ian M. Catlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian M. Catlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Catlett. The network helps show where Ian M. Catlett may publish in the future.

Co-authorship network of co-authors of Ian M. Catlett

This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Catlett. A scholar is included among the top collaborators of Ian M. Catlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Catlett. Ian M. Catlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 6
4 2
5 3
6 1
7 6
8 1
9
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trialbreakdown →
139
10 51
11 88
12 136
13 167
14 9
15 26
16 7
17 35
18 30
19 171
20 35

About Ian M. Catlett

Ian M. Catlett is a scholar working on Oncology, Rheumatology and Genetics, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (19 papers), Systemic Lupus Erythematosus Research (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). The work is most often cited by research in Immunology (632 citations), Rheumatology (214 citations) and Hepatology (108 citations). Ian M. Catlett has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Gail A. Bishop, Bruce S. Hostager, Ihab Girgis, Dennis M. Grasela, Subhashis Banerjee, Scott C. Brakenridge, Craig M. Coopersmith, Richard S. Hotchkiss, Lyle L. Moldawer and Florian Mayr. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026